Stock listing
Munich:IGS1 IGC Pharma, Inc. Aktie
German listing (Munich) of IGC Pharma, Inc. · home listing NYSE American:IGC
Follow IGC Pharma, Inc. into a list and get an email when it puts out news.
Home listing price · AMEX:IGC
$0.185 USD -0.014 (-7.1%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, AMEX:IGC
- Day range
- $0.181 – $0.197 USDOct 30, 2026
- Volume
- 504,332 sharesOct 30, 2026
- Market cap
- $19.13M USDAt the close on Oct 30, 2026 · price × 103.4M shares outstanding
- 52-week range
- $0.080 – $0.450 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $205,490 USDMedian day 535,212 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE American:IGC · Home | $0.185 USD | -0.014 (-7.1%) | 504,332 | $0.191 | $0.197 | $0.181 | $0.199 | Close on Oct 30, 2026 |
| Frankfurt:IGS1 | €0.173 EUR | -0.045 (-20.6%) | — | €0.173 | €0.173 | €0.173 | €0.218 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · AMEX:IGC · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.185 | -0.014 | -7.1% | $0.191 | $0.197 | $0.181 | 504,332 | |
| $0.199 | -0.040 | -16.5% | $0.245 | $0.245 | $0.080 | 2,007,404 | |
| $0.239 | -0.009 | -3.7% | $0.250 | $0.251 | $0.238 | 509,508 | |
| $0.248 | -0.002 | -0.8% | $0.246 | $0.250 | $0.245 | 118,314 | |
| $0.250 | 0.000 | 0.0% | $0.245 | $0.253 | $0.243 | 323,314 | |
| $0.250 | 0.000 | 0.0% | $0.250 | $0.250 | $0.240 | 124,200 | |
| $0.250 | +0.010 | +4.2% | $0.250 | $0.250 | $0.240 | 175,200 | |
| $0.240 | -0.010 | -4.0% | $0.250 | $0.250 | $0.240 | 364,800 | |
| $0.250 | +0.010 | +4.2% | $0.240 | $0.250 | $0.240 | 446,100 | |
| $0.240 | -0.010 | -4.0% | $0.250 | $0.270 | $0.240 | 541,100 | |
| $0.250 | 0.000 | 0.0% | $0.260 | $0.260 | $0.240 | 406,000 | |
| $0.250 | 0.000 | 0.0% | $0.260 | $0.260 | $0.250 | 781,400 | |
| $0.250 | -0.020 | -7.4% | $0.260 | $0.260 | $0.250 | 946,100 | |
| $0.270 | -0.010 | -3.6% | $0.270 | $0.270 | $0.260 | 422,100 | |
| $0.280 | 0.000 | 0.0% | $0.280 | $0.290 | $0.270 | 573,000 | |
| $0.280 | 0.000 | 0.0% | $0.280 | $0.280 | $0.280 | 232,200 | |
| $0.280 | 0.000 | 0.0% | $0.280 | $0.290 | $0.280 | 626,400 | |
| $0.280 | 0.000 | 0.0% | $0.290 | $0.290 | $0.280 | 306,800 | |
| $0.280 | 0.000 | 0.0% | $0.280 | $0.290 | $0.280 | 1,111,900 | |
| $0.280 | +0.010 | +3.7% | $0.280 | $0.290 | $0.270 | 1,768,500 | |
| $0.270 | 0.000 | 0.0% | $0.280 | $0.280 | $0.270 | 630,600 | |
| $0.270 | 0.000 | 0.0% | $0.270 | $0.280 | $0.270 | 449,900 | |
| $0.270 | 0.000 | 0.0% | $0.270 | $0.280 | $0.270 | 808,900 | |
| $0.270 | 0.000 | 0.0% | $0.280 | $0.280 | $0.270 | 523,700 | |
| $0.270 | -0.010 | -3.6% | $0.290 | $0.300 | $0.270 | 1,102,300 | |
| $0.280 | 0.000 | 0.0% | $0.280 | $0.290 | $0.280 | 681,600 | |
| $0.280 | -0.010 | -3.4% | $0.280 | $0.290 | $0.280 | 332,800 | |
| $0.290 | +0.010 | +3.6% | $0.290 | $0.290 | $0.280 | 540,500 | |
| $0.280 | +0.010 | +3.7% | $0.270 | $0.280 | $0.270 | 609,700 | |
| $0.270 | -0.020 | -6.9% | $0.290 | $0.290 | $0.270 | 507,100 | |
| $0.290 | +0.020 | +7.4% | $0.270 | $0.290 | $0.270 | 811,600 | |
| $0.270 | 0.000 | 0.0% | $0.280 | $0.290 | $0.270 | 713,500 | |
| $0.270 | 0.000 | 0.0% | $0.270 | $0.280 | $0.270 | 473,500 | |
| $0.270 | -0.010 | -3.6% | $0.270 | $0.280 | $0.270 | 501,000 | |
| $0.280 | 0.000 | 0.0% | $0.280 | $0.280 | $0.270 | 819,500 | |
| $0.280 | 0.000 | 0.0% | $0.290 | $0.290 | $0.280 | 413,600 | |
| $0.280 | 0.000 | 0.0% | $0.290 | $0.290 | $0.280 | 615,400 | |
| $0.280 | -0.010 | -3.4% | $0.300 | $0.300 | $0.280 | 344,900 | |
| $0.290 | -0.010 | -3.3% | $0.300 | $0.300 | $0.290 | 571,100 | |
| $0.300 | 0.000 | 0.0% | $0.300 | $0.300 | $0.300 | 372,600 | |
| $0.300 | 0.000 | 0.0% | $0.300 | $0.300 | $0.300 | 345,600 | |
| $0.300 | 0.000 | 0.0% | $0.300 | $0.300 | $0.300 | 457,000 | |
| $0.300 | 0.000 | 0.0% | $0.300 | $0.310 | $0.300 | 774,700 | |
| $0.300 | -0.010 | -3.2% | $0.310 | $0.320 | $0.290 | 619,100 | |
| $0.310 | -0.020 | -6.1% | $0.330 | $0.340 | $0.310 | 926,100 | |
| $0.330 | +0.020 | +6.5% | $0.310 | $0.340 | $0.310 | 3,598,300 | |
| $0.310 | +0.005 | +1.8% | $0.310 | $0.310 | $0.300 | 453,000 | |
| $0.305 | +0.004 | +1.3% | $0.301 | $0.308 | $0.300 | 387,273 | |
| $0.301 | -0.009 | -3.0% | $0.310 | $0.310 | $0.300 | 916,488 | |
| $0.310 | +0.030 | +10.7% | $0.290 | $0.310 | $0.280 | 1,867,400 | |
| $0.280 | -0.010 | -3.4% | $0.290 | $0.290 | $0.270 | 603,600 | |
| $0.290 | +0.006 | +2.0% | $0.280 | $0.290 | $0.280 | 1,075,500 | |
| $0.284 | +0.004 | +1.6% | $0.288 | $0.288 | $0.275 | 529,924 | |
| $0.280 | -0.020 | -6.7% | $0.285 | $0.288 | $0.271 | 1,048,091 | |
| $0.300 | +0.010 | +3.4% | $0.300 | $0.300 | $0.290 | 1,541,200 | |
| $0.290 | 0.000 | 0.0% | $0.290 | $0.300 | $0.280 | 2,248,600 | |
| $0.290 | +0.010 | +3.6% | $0.280 | $0.290 | $0.280 | 1,693,900 | |
| $0.280 | +0.010 | +3.7% | $0.270 | $0.290 | $0.270 | 2,634,800 | |
| $0.270 | +0.010 | +3.8% | $0.260 | $0.270 | $0.250 | 618,800 | |
| $0.260 | +0.010 | +4.0% | $0.250 | $0.260 | $0.250 | 460,700 | |
| $0.250 | 0.000 | 0.0% | $0.250 | $0.250 | $0.250 | 312,900 | |
| $0.250 | 0.000 | 0.0% | $0.260 | $0.260 | $0.250 | 208,100 | |
| $0.250 | 0.000 | 0.0% | $0.250 | $0.260 | $0.240 | 307,700 | |
| $0.250 | 0.000 | 0.0% | $0.260 | $0.260 | $0.240 | 376,100 | |
| $0.250 | 0.000 | 0.0% | $0.260 | $0.260 | $0.250 | 184,800 | |
| $0.250 | +0.010 | +4.2% | $0.250 | $0.250 | $0.240 | 255,100 |
- Ticker
- Munich:IGS1
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Munich
- Currency
- EUR
What changed lately
Latest news release · Oct 13, 2026
IGC Pharma Unveils PRISM AI Platform to Move Alzheimer's Risk Prediction to Brain-Health Action and Commercial Deployment
Latest deck · Jul 14, 2026
Investor Presentation (July 2026)
Investor deck · 25 slides
Latest news
IGC Pharma Unveils PRISM AI Platform to Move Alzheimer's Risk Prediction to Brain-Health Action and Commercial Deployment
Oct 13, 2026
Closed $0.27 (-3.6%) on Oct 13, 2026
IGC Pharma Completes Enrollment in Phase 2 CALMA Alzheimer's Trial; Topline Results Expected Q4 2026
Sep 28, 2026
Closed $0.27 (-3.6%) on Sep 28, 2026
IGC Pharma Reports Q2 2026 Results as CALMA Alzheimer's Trial Moves Within Six Randomizations of Enrollment Closure
Aug 17, 2026
Closed $0.28 (-6.7%) on Aug 17, 2026
IGC Pharma Strengthens Regulatory Readiness as Phase 2 CALMA Alzheimer's Trial Approaches Enrollment Closure and Q4 Topline Readout
Aug 11, 2026
Closed $0.28 (+3.7%) on Aug 11, 2026
IGC Pharma Evaluates Potential Recovery Options as Federal Jury Verdict Brings Renewed Attention to 2018 IGC Short Campaign
Jul 29, 2026
Closed $0.24 (-7.3%) on Jul 29, 2026
IGC Pharma CEO and Principal Financial Officer Purchase More Than $1.15 Million of Common Stock Directly from the Company
Jul 7, 2026
Closed $0.28 (0.0%) on Jul 7, 2026
IGC Pharma (NYSE: IGC) CEO and CFO Acquire More Than 4.2 Million Shares
Jul 2, 2026
Closed $0.28 (+3.7%) on Jul 2, 2026
IGC Pharma Reports First Quarter 2026 Financial Results with CALMA Phase 2 in the final stage, with 80% Enrollment
May 19, 2026
Closed $0.28 (0.0%) on May 20, 2026
IGC Pharma to Present Tau-PET Biomarker Research at 2026 Global Tau Conference
May 15, 2026
Closed $0.29 (-3.3%) on May 15, 2026
IGC Pharma Adds Kerwin Medical Center in Dallas to Phase 2 CALMA Trial as Enrollment Advances Toward Completion
Apr 22, 2026
Closed $0.35 (+9.4%) on Apr 22, 2026
Decks
Investor Presentation (July 2026)
Investor deck · 25 slides · Jul 14, 2026
Investor Presentation (June 2025)
Investor deck · 50 slides · Jun 17, 2025
FY2025 Earnings Presentation
Earnings · 20 slides · June 2025
Investor Presentation (April 2025)
Investor deck · 28 slides · April 2025
IGC Pharma, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 40 in the last 12 months · 64 in all · newest Oct 13, 2026 · oldest 2025
- Decks
- 14 decks · latest Jul 14, 2026
Where IGC Pharma, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE American:IGC · Home listing | NYSE American | United States | USD |
| gettex:IGS1 | gettex | Germany | EUR |
| LS Exchange:A1T87A | LS Exchange | Germany | EUR |
| Lang & Schwarz:A1T87A | Lang & Schwarz | Germany | EUR |
| BOATS:IGC | BOATS | United States | USD |
| Dusseldorf:IGS1 | Dusseldorf | Germany | EUR |
| Frankfurt:IGS1 | Frankfurt | Germany | EUR |
| Munich:IGS1 · This page | Munich | Germany | EUR |
| Stuttgart:IGS1 | Stuttgart | Germany | EUR |
| Tradegate:IGS1 | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about IGC Pharma, Inc.